Delivery Order SPE2DB22D3016-SPE2DB25FAUT3
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for $1,345.47 to supply Sunosi 150 mg tablets (30-count packages). This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a non-competitive, non-set-aside award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal...
- The Defense Logistics Agency awarded a $1,154.87 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Sunosi 150 mg tablets (30-count packages) valued at $1,289.19. This firm fixed-price delivery order will be completed by August 19, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award was not set aside for...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.60 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract represents a direct procurement action under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a $4,025.37 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,866.80 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Sunosi 150 mg tablets (30-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,404.99 for 30 tablets of Sunosi 75 mg on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and represents a child award under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $1,817.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Sunosi 150 mg, with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAUT3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,345.47 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Sunosi 150 mg tablets (30-unit quantity). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 25, 2025. The award was made to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, which serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains. AmerisourceBergen's successful performance on competitively awarded contracts demonstrates its capability to fulfill federal medical supply requirements across diverse product categories and price points.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/24/25 |